Evaluation of T Cell Immunity against Human Cytomegalovirus: Impact on Patient Management and Risk Assessment of Vertical Transmission

Cytomegalovirus (CMV) is one of the most common infectious agents, infecting the general population at an early age without causing morbidity most of the time. However, on particular occasions, it may represent a serious risk, as active infection is associated with rejection and disease after solid...

Full description

Bibliographic Details
Main Authors: Giulia Freer, Paola Quaranta, Mauro Pistello
Format: Article
Language:English
Published: Hindawi Limited 2016-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2016/9384813
id doaj-c2aa85a3588b44fcb73bd1e6e5ed6dfd
record_format Article
spelling doaj-c2aa85a3588b44fcb73bd1e6e5ed6dfd2020-11-25T00:15:23ZengHindawi LimitedJournal of Immunology Research2314-88612314-71562016-01-01201610.1155/2016/93848139384813Evaluation of T Cell Immunity against Human Cytomegalovirus: Impact on Patient Management and Risk Assessment of Vertical TransmissionGiulia Freer0Paola Quaranta1Mauro Pistello2Retrovirus Center, Department of Translational Research, University of Pisa, Via del Brennero 2, 56127 Pisa, ItalyRetrovirus Center, Department of Translational Research, University of Pisa, Via del Brennero 2, 56127 Pisa, ItalyRetrovirus Center, Department of Translational Research, University of Pisa, Via del Brennero 2, 56127 Pisa, ItalyCytomegalovirus (CMV) is one of the most common infectious agents, infecting the general population at an early age without causing morbidity most of the time. However, on particular occasions, it may represent a serious risk, as active infection is associated with rejection and disease after solid organ transplantation or fetal transmission during pregnancy. Several methods for CMV diagnosis are available on the market, but because infection is so common, careful selection is needed to discriminate primary infection from reactivation. This review focuses on methods based on CMV-specific T cell reactivity to help monitor the consequences of CMV infection/reactivation in specific categories of patients. This review makes an attempt at discussing the pros and cons of the methods available.http://dx.doi.org/10.1155/2016/9384813
collection DOAJ
language English
format Article
sources DOAJ
author Giulia Freer
Paola Quaranta
Mauro Pistello
spellingShingle Giulia Freer
Paola Quaranta
Mauro Pistello
Evaluation of T Cell Immunity against Human Cytomegalovirus: Impact on Patient Management and Risk Assessment of Vertical Transmission
Journal of Immunology Research
author_facet Giulia Freer
Paola Quaranta
Mauro Pistello
author_sort Giulia Freer
title Evaluation of T Cell Immunity against Human Cytomegalovirus: Impact on Patient Management and Risk Assessment of Vertical Transmission
title_short Evaluation of T Cell Immunity against Human Cytomegalovirus: Impact on Patient Management and Risk Assessment of Vertical Transmission
title_full Evaluation of T Cell Immunity against Human Cytomegalovirus: Impact on Patient Management and Risk Assessment of Vertical Transmission
title_fullStr Evaluation of T Cell Immunity against Human Cytomegalovirus: Impact on Patient Management and Risk Assessment of Vertical Transmission
title_full_unstemmed Evaluation of T Cell Immunity against Human Cytomegalovirus: Impact on Patient Management and Risk Assessment of Vertical Transmission
title_sort evaluation of t cell immunity against human cytomegalovirus: impact on patient management and risk assessment of vertical transmission
publisher Hindawi Limited
series Journal of Immunology Research
issn 2314-8861
2314-7156
publishDate 2016-01-01
description Cytomegalovirus (CMV) is one of the most common infectious agents, infecting the general population at an early age without causing morbidity most of the time. However, on particular occasions, it may represent a serious risk, as active infection is associated with rejection and disease after solid organ transplantation or fetal transmission during pregnancy. Several methods for CMV diagnosis are available on the market, but because infection is so common, careful selection is needed to discriminate primary infection from reactivation. This review focuses on methods based on CMV-specific T cell reactivity to help monitor the consequences of CMV infection/reactivation in specific categories of patients. This review makes an attempt at discussing the pros and cons of the methods available.
url http://dx.doi.org/10.1155/2016/9384813
work_keys_str_mv AT giuliafreer evaluationoftcellimmunityagainsthumancytomegalovirusimpactonpatientmanagementandriskassessmentofverticaltransmission
AT paolaquaranta evaluationoftcellimmunityagainsthumancytomegalovirusimpactonpatientmanagementandriskassessmentofverticaltransmission
AT mauropistello evaluationoftcellimmunityagainsthumancytomegalovirusimpactonpatientmanagementandriskassessmentofverticaltransmission
_version_ 1725387177873899520